Fluid biomarkers in the human prion diseases

AGB Thompson, SH Mead - Molecular and Cellular Neuroscience, 2019 - Elsevier
The human prion diseases are a diverse set of often rapidly progressive neurodegenerative
conditions associated with abnormal forms of the prion protein. We review work to establish …

The Medical Research Council prion disease rating scale: a new outcome measure for prion disease therapeutic trials developed and validated using systematic …

AGB Thompson, J Lowe, Z Fox, A Lukic, MC Porter… - Brain, 2013 - academic.oup.com
Progress in therapeutics for rare disorders like prion disease is impeded by the lack of
validated outcome measures and a paucity of natural history data derived from prospective …

[HTML][HTML] Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseases

AGB Thompson, P Anastasiadis, R Druyeh… - Molecular …, 2021 - nature.com
Prion diseases are fatal neurodegenerative conditions with highly accurate CSF and imaging
diagnostic tests, but major unmet needs for blood biomarkers. Using ultrasensitive immuno-…

[HTML][HTML] A blood miRNA signature associates with sporadic Creutzfeldt-Jakob disease diagnosis

PJ Norsworthy, AGB Thompson, TH Mok… - Nature …, 2020 - nature.com
Sporadic Creutzfeldt-Jakob disease (sCJD) presents as a rapidly progressive dementia
which is usually fatal within six months. No clinical blood tests are available for diagnosis or …

High energy neutral atom (HENA) imager for the IMAGE mission

…, BE Tossman, JD Boldt, JR Hayes, GB Andrews… - The IMAGE …, 2000 - Springer
The IMAGE mission will be the first of its kind, designed to comprehensively image a variety
of emissions from the Earth’s magnetosphere, with sufficient time resolution to follow the …

[HTML][HTML] Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery

…, GB Thompson, FJ Service, JC Andrews… - … England Journal of …, 2005 - Mass Medical Soc
<p id="p001">We describe six patients (five women and one man; median age, 47 years;
range, 39 to 54) with postprandial symptoms of neuroglycopenia owing to endogenous …

Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987–2007

KA Placzkowski, A Vella, GB Thompson… - The Journal of …, 2009 - academic.oup.com
Objective: The objective of the study was to assess changes in the presentation and diagnostic
and radiological evaluation of patients with surgically confirmed insulinoma at the Mayo …

Preoperative detection of pancreatic insulinomas on multiphasic helical CT

…, JC Andrews, GB Thompson… - American Journal of …, 2003 - Am Roentgen Ray Soc
OBJECTIVE. The objective was to analyze enhancement characteristics of insulinomas and
to determine the ability of multiphase CT to localize these tumors. MATERIALS AND …

Brainstem phenotype of cathepsin A–related arteriopathy with strokes and leukoencephalopathy

…, I Davagnanam, AGB Thompson… - Neurology …, 2017 - AAN Enterprises
Cathepsin A–related arteriopathy with strokes and leukoencephalopathy (CARASAL) is a
recently identified cause of adult-onset cerebral leukodystrophy due to CTSA gene mutations …

Noninsulinoma pancreatogenous hypoglycemia: a novel syndrome of hyperinsulinemic hypoglycemia in adults independent of mutations in Kir6. 2 and SUR1 genes

FJ Service, N Natt, GB Thompson… - The Journal of …, 1999 - academic.oup.com
In adults, endogenous hyperinsulinemic hypoglycemia is almost invariably due to insulinoma.
In these patients with insulinoma, neuroglycopenic episodes exclusively after meal …